Volume No. :   6

Issue No. :  4

Year :  2014

ISSN Print :  0975-4407

ISSN Online :  2321-5836


Allready Registrered
Click to Login

An Ebola: Overview

Address:   Dudhal S.C.1*, Hapse S.A.1, Kothule M.B. 2
1Department of Quality Assurance Technique, P.D.V.V.P.F’S College of Pharmacy, Ahmednagar
2H.S.B.P.V.T. College of Pharmacy, Kashti Tal. Shrigonda, Ahmednagar
*Corresponding Author
DOI No: Not Available

Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys and chimpanzees) that has appeared sporadically since its initial recognition in 1976.Most species of ebolavirus and the only known species of virus occur in Africa. Primates are infected sporadically from an unknown source; current evidence suggests that the reservoir hosts are probably bats. Humans seem to become infected directly from bats in caves, as well as when they contact tissues from infected apes and other species. Once the virus has entered the population, it can spread from person to person. Some epidemics affect hundreds of people and decimate entire villages, particularly where hospital facilities and medical supplies are inadequate and nosocomial spread occurs. Although the mortality rate varies, the most pathogenic viruses kill up to 90% of those who become infected. No vaccine is available, and the only treatment is supportive.
Ebola virus disease, Haemorrhagic fever, Ebola virus outbreak.
Dudhal SC, Hapse SA, Kothule MB. An Ebola: Overview. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(4): 204-209.
[View HTML]      [View PDF]

Visitor's No. :   155000